Low-protein Formula Supplements in Chronic Kidney Disease
Effect of Low-protein Formula Nutritional Supplements on Renal Function Progression, Muscle Mass and Physical Activity With Chronic Kidney Disease
1 other identifier
interventional
95
1 country
1
Brief Summary
Prospective randomized contorl study.Comparing clinical outcome between chronic kidney disease who were prescribed 6% low-protein nutrition supplement along with dietatian regular nutrition education and those without oral nutrition supplement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
April 8, 2022
CompletedApril 8, 2022
March 1, 2022
1.1 years
March 15, 2022
March 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Change of muscle strength
Hand grip strength
Baseline to 12 weeks and 24 weeks
Change of Gait speed
Gait speed measurement
Baseline to 12 weeks and 24 weeks
Change of 5-meter distance walk
5-meter distance walk measurement
Baseline to 12 weeks and 24 weeks
Change of nutrition status
Mini Nutritional Assessment Short-Form score
Baseline to 12 weeks and 24 weeks
Change of body composition
Using bioelectrical impedance analysis(BIA, Tanita MC-780, Japan)
Baseline to 12 weeks and 24 weeks
Change of total energy intake
24-hour dietary record measurement
Baseline to 12 weeks and 24 weeks
Change of protein intake
24-hour dietary record measurement
Baseline to 12 weeks and 24 weeks
Change of carbohydrate intake
24-hour dietary record measurement
Baseline to 12 weeks and 24 weeks
Change of fat intake
24-hour dietary record measurement
Baseline to 12 weeks and 24 weeks
Change of micronutrients intake
24-hour dietary record measurement
Baseline to 12 weeks and 24 weeks
Secondary Outcomes (21)
Change of serum creatinine
Baseline to 12 weeks and 24 weeks
Change of blood urea nitrogen
Baseline to 12 weeks and 24 weeks
Change of estimated glomerular filtration rate
Baseline to 12 weeks and 24 weeks
Change of daily protein intake.
Baseline to 12 weeks and 24 weeks
Change of albumin
Baseline to 12 weeks and 24 weeks
- +16 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALRegular nutrition education and supply one serving per day of 6% low protein formula.
Regular nutrition education
PLACEBO COMPARATORRegular nutrition education
Interventions
dietitian regular nutrition education which was following a low protein diet and supply one serving per day of 6 % low protein formula (200mL,2kcal/ml) for 24 weeks
dietitian regular nutrition educataion which was following a low protein diet
Eligibility Criteria
You may qualify if:
- Subject is \>65years of age.
- Subject has been diagnosed with Chronic Kidney Disease (CKD) and is classified as being between Stages 3 to 5.
You may not qualify if:
- The physician determines that the clinical condition is unstable.
- Lower limb injury or severe edema.
- food allergies to milk, or fish
- There is a heart rhythm in the body and a prosthetic device.
- Those who are unable to complete the questionnaire due to severe cognitive impairment as determined by the physician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taichung Verterans General Hospital Taichung
Taichung, Taiwan
Related Publications (1)
Yang WC, Hsieh HM, Chen JP, Liu LC, Chen CH. Effects of a low-protein nutritional formula with dietary counseling in older adults with chronic kidney disease stages 3-5: a randomized controlled trial. BMC Nephrol. 2023 Dec 14;24(1):372. doi: 10.1186/s12882-023-03423-8.
PMID: 38097963DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheng-Hsu Chen, MDPHD
Division of Nephrology in Taichung Veterans General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2022
First Posted
April 8, 2022
Study Start
September 25, 2019
Primary Completion
October 31, 2020
Study Completion
December 31, 2021
Last Updated
April 8, 2022
Record last verified: 2022-03